Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2026-01-19 @ 9:15 PM
Study NCT ID:
NCT03556358
Status:
COMPLETED
Last Update Posted:
2022-01-14
First Post:
2018-06-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer
Sponsor:
Tanvex BioPharma USA, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TX05-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None